New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
About this episode
This episode features an interview with experts discussing the new definition of light chain monoclonal gammopathy of undetermined significance.
Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
More episodes of JAMA Oncology Author Interviews
- Metastatic Recurrence Among Adolescents and Young Adults With Cancer
- Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
- Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
- Proportional Sedation for Persistent Agitated Delirium in Palliative Care
- Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
- Accelerated Aging in Survivors of Childhood Cancer
Explore listener stats, chart rankings, contacts and more on the JAMA Oncology Author Interviews podcast page.